✦ LIBER ✦

P1-065: Oxidative load regulates amyloid burden in vitro and in vivo in an APP X PS1 transgenic mouse model of Alzheimer's disease

✍ Scribed by Fahd Choudhry; Paul T. Francis; David R. Howlett; Jill R.C. Richardson; Robert J. Williams

Book ID: 118464237
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 59 KB
Volume: 4
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2008.05.651

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Axonopathy in an APP/PS1 transgenic mous

Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer’s disease

✍ Oliver Wirths; Joachim Weis; Jacek Szczygielski; Gerd Multhaup; Thomas A. Bayer 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 1006 KB

P1-028: Axonopathy in APP/PS1 transgenic

P1-028: Axonopathy in APP/PS1 transgenic mouse models of Alzheimer’s disease

✍ Oliver Wirths; Joachim Weis; Rakez Kayed; Takaomi C. Saido; Thomas A. Bayer 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Coenzyme Q10 Reduces β-Amyloid Plaque in

Coenzyme Q10 Reduces β-Amyloid Plaque in an APP/PS1 Transgenic Mouse Model of Alzheimer’s Disease

✍ Xifei Yang; George Dai; Geng Li; Edward S. Yang 📂 Article 📅 2009 🏛 Humana Press Inc 🌐 English ⚖ 160 KB

Sensorimotor gating and memory deficits

Sensorimotor gating and memory deficits in an APP/PS1 double transgenic mouse model of Alzheimer's disease

✍ Hongxing Wang; Jue He; Ruiguo Zhang; Shenghua Zhu; Junhui Wang; Lynda Kong; Qing 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 637 KB

Increased hippocampal neurogenesis in th

Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model

✍ Yingxin Yu; Jue He; Yanbo Zhang; Huanmin Luo; Shenghua Zhu; Yi Yang; Tou Zhao; J 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB

## Abstract Alzheimer's disease (AD) is a progressive neurodegenerative disease associated with senile β‐amyloid (Aβ) plaques and cognitive decline. Neurogenesis in the adult hippocampus is implicated in regulating learning and memory, and is increased in human postmortem brain of AD patients. Howe

The incretin analogue D-Ala2GIP reduces

The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer’s disease

✍ Duffy, A.M.; Hölscher, C. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 857 KB